Paramount Capital is a global privately-held pharmaceutical development and healthcare investment firm. It primarily invests in the technology and biotechnology sector.
787 7th Avenue
New York, United States
|2007-03-20||Neose Technologies||Unattributed VC - IV||$43.26M||Abingworth, Baker Brothers Investments, Balyasny Asset Management, Bellevue Asset Management, Bristol Capital Advisors, Domain Associates, Downsview Capital, Dp V Associates Lp, Iroquois Capital Group, Medical Strategy, MHR Fund Management, MPM Capital, Oppenheim Pramerica Asset Management, OrbiMed Advisors, Potomac Capital Management, Tang Capital Management, and Visium Asset Management|
|2007-02-19||Genelabs Technologies||Unattributed VC - II||$9.49M||Baker Brothers Investments, Bass Companies, BVF Partners, Centrecourt, First Eagle Investment Management, Heights Capital Management, Lehman Brothers, MPM Capital, and SF Capital Group|
|2006-12-21||RegeneRx Biopharmaceuticals||PIPE||$9.55M||Crestview Capital Funds, Defiante Farmaceutica L.d.a, Diamond Asset Management Llc, Enable Capital Management, Nite Capital Management, sigma-tau s.p.a., Straus Capital Management, and Sunrise Equity Partners|
|2006-11-24||Orchid Cellmark||Unattributed VC - V||$14.04M||Accipiter Capital Management, Atoll Asset Management, Downsview Capital, Heights Capital Management, Hudson Bay Capital Management, Iroquois Capital Group, Lehman Brothers, Potomac Capital Management, and UBS|
|2006-11-13||PhotoMedex||Unattributed VC - IV||$11.42M||Enable Capital Management, Hudson Bay Capital Management, Iroquois Capital Group, and P.A.W. Capital Partners|